Companies are deploying quantum platforms for molecular drug design and catalyst optimization, with chemistry products reaching market 2028-2030 and therapeutics 2035+. Early results include batteries using 70% less lithium.
@informaq.bsky.socialExplore
@informaq.bsky.social@informaq.bsky.socialAstraZeneca and Riverlane identified nine drug discovery areas where quantum computers could excel, including protein binding calculations, molecular dynamics simulation, and drug synthesis prediction—unlocking new therapeutic possibilities.